Anti-Human DBI Polyclonal Antibody

Binds medium- and long-chain acyl-CoA esters with very high affinity and may function as an intracellular carrier of acyl-CoA esters. It is also able to displace diazepam from the benzodiazepine (BZD) recognition site located on the GABA type A receptor. It is therefore possible that this protein also acts as a neuropeptide to modulate the action of the GABA receptor.
List Price: $398
  • Buy 5 for $378.1 each and save 5%
  • Buy 21 for $358.2 each and save 10%
  • Buy 31 for $338.3 each and save 15%
  • Buy 51 for

Properties

Data Sheet Click for Datasheet
Catalog Number PA02976
Size 100μl
Host Type Rabbit
Immunogen Synthesized peptide derived from the Internal region of human ACBP.
Specificity Isoform 1 is ubiquitous, with a moderate expression level. Isoform 2 is ubiquitous with high level in liver and adipose tissue. Isoform 3 is ubiquitous with strong expression in adipose tissue and heart.
Isotype IgG
Reacitivity Human
Clone
Uniprot P07108
Concentration 1mg/mL
Dilution WB 1:500-1:2000, IHC 1:100-1:300, ELISA 1:10000
Formulation
Application WB,IHC-p,ELISA
Other Names ACBD 1,ACBD1,ACBP,ACBP,Acyl CoA binding domain containing 1,Acyl CoA binding protein,Acyl Coenzyme A binding domain containing 1,Acyl coenzyme A binding protein,Acyl-CoA-binding protein,CCK RP,CCKRP,Cholecystokinin releasing peptide trypsin sensitive,DBI,Diazepam-binding inhibitor,Endozepine,EP,GABA receptor modulator,MGC70414
Storage Lyophilized product: 5 years at 2 - 8°C; Solution: 2 years at -20°C.
Postscript For research use only, not for use in diagnostic procedures.

© Copyright 2024 TZYBIOTECH. All Rights Reserved. SiteMap